Principal Investigator
Enrollment Status
Clinical Trial ID
Clinical Trial Summary
The purpose of this study is to design and refine a web-based platform developed for managing
symptom burden in men who have sex who are HIV+ cancer survivors.
Phase
N/A
Funding Agency/Sponsor
Externally Peer-Reviewed
Disease
Population Sciences
Enrollment Eligibility
Inclusion Criteria:
1. Age: 18 years or older
2. Fluent in English
3. Have evidence of at least one form of non-metastatic solid tumor cancer or blood
cancer
4. Be at least 30 days post active primary cancer treatment
5. Self identify as a sexual minority cisgender man
6. Self-report having been diagnosed with HIV
7. Have reliable access to a computer/device with internet accessibility
Exclusion Criteria:
1. Have had one of the following exclusionary cancer types: Non-melanoma skin cancer,
brain cancer, eye cancer, history of some form of pediatric cancer (if that is
participant's only cancer diagnosis)
2. History of advanced (metastatic) cancer of any type
3. Inpatient treatment for severe mental illness in the past 12 months and/or suicidality
of moderate or greater risk
4. Appears actively intoxicated or otherwise unable to provide full informed consent
5. Have any other medical condition resulting in predicted live expectancy of less than
12 months